We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
-15.2%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.18B
AUM Growth
-$173M
Cap. Flow
+$50M
Cap. Flow %
4.25%
Top 10 Hldgs %
31.89%
Holding
2,429
New
979
Increased
279
Reduced
240
Closed
895

Sector Composition

Rank Sector Weight
1 Technology 14.05%
2 Healthcare 13.79%
3 Financials 8.37%
4 Communication Services 8.09%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOC
1276
DELISTED
Biocept, Inc.
BIOC
$27K ﹤0.01%
+940
New +$42.8K
DS
1277
DELISTED
Drive Shack Inc.
DS
$27K ﹤0.01%
+19,654
New +$28K
PAVM icon
1278
PAVmed
PAVM
$33.7M
$26K ﹤0.01%
+62
New +$30K
SXTC icon
1279
China SXT Pharmaceuticals
SXTC
$1.87M
0
WDH
1280
Waterdrop
WDH
$359M
$26K ﹤0.01%
+20,252
New +$26.8K
WWR icon
1281
Westwater Resources
WWR
$77.2M
$26K ﹤0.01%
23,946
-39,975
-63% -$52.1K
NTBL
1282
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$26K ﹤0.01%
+458
New +$25K
CANO.WS
1283
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$26K ﹤0.01%
+37,636
New +$39K
ATNX
1284
DELISTED
Athenex, Inc. Common Stock
ATNX
$26K ﹤0.01%
+3,155
New +$35.2K
EVGOW
1285
DELISTED
EVgo Inc Warrants
EVGOW
$25K ﹤0.01%
+20,076
New +$47.4K
MYO icon
1286
Myomo
MYO
$59.8M
$25K ﹤0.01%
+14,634
New +$38.3K
RCON icon
1287
Recon Technology
RCON
$2.81M
$25K ﹤0.01%
+2,058
New +$31K
FTH
1288
Faeth Therapeutics
FTH
$773M
$25K ﹤0.01%
+561
New +$21K
YARW
1289
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
$25K ﹤0.01%
72
+45
+167% +$18.9K
LIAN
1290
DELISTED
LianBio American Depositary Shares
LIAN
$25K ﹤0.01%
+11,740
New +$39.9K
ELVT
1291
DELISTED
Elevate Credit, Inc.
ELVT
$25K ﹤0.01%
+10,409
New +$28.2K
EXN
1292
DELISTED
Excellon Resources Inc.
EXN
$25K ﹤0.01%
56,620
+41,140
+266% +$25.9K
MITO
1293
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$25K ﹤0.01%
+100,291
New +$34.5K
SPI
1294
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$25K ﹤0.01%
14,522
-53,993
-79% -$115K
DOYU
1295
DouYu International Holdings
DOYU
$139M
$24K ﹤0.01%
2,032
+403
+25% +$6.17K
HEPS
1296
D-Market Electronic Services & Trading
HEPS
$1.04B
$24K ﹤0.01%
+38,927
New +$56.6K
IGC icon
1297
IGC Pharma
IGC
$29.3M
$24K ﹤0.01%
44,970
+22,262
+98% +$14K
PSHG icon
1298
Performance Shipping
PSHG
$21.9M
$24K ﹤0.01%
+2,862
New +$82.1K
PZG icon
1299
Paramount Gold Nevada
PZG
$132M
$24K ﹤0.01%
53,756
-88,833
-62% -$48.8K
SONM icon
1300
DNA X Inc
SONM
$5.36M
$24K ﹤0.01%
+246
New +$27.8K

Similar funds

Virtu Financial's Q2 2022 Portfolio in Review

As of Q2 2022, Virtu Financial held 2,429 positions worth $1.18B, down 13% from $1.35B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Virtu Financial deployed $50M of net new capital in Q2 2022, opening 979 new positions and adding to 279 existing holdings. Its largest new stake was CMC Materials, Inc. Common Stock: 361,092 shares worth $63M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $258M trimmed.

  • Virtu Financial's largest Q2 2022 buy was CMC Materials, Inc. Common Stock: 361,092 shares worth $63M.
  • Virtu Financial added most to Coherent Inc in Q2 2022, an estimated $62.2M increase.
  • Virtu Financial's biggest Q2 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $258M.
  • Virtu Financial fully exited People's United Financial Inc in Q2 2022, selling an estimated $105M.
  • Virtu Financial's ten largest holdings make up 32% of its $1.18B portfolio in Q2 2022.
  • Virtu Financial opened 979 new positions and closed 895 in Q2 2022.
  • Virtu Financial's portfolio value fell 13% quarter-over-quarter to $1.18B.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.